111 related articles for article (PubMed ID: 12295471)
1. Public / private partnership: developing an oral treatment for visceral leishmaniasis.
Mattock N
TDR News; 1999 Oct; (60):1-2. PubMed ID: 12295471
[TBL] [Abstract][Full Text] [Related]
2. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
[TBL] [Abstract][Full Text] [Related]
3. Advances in battle against leishmaniasis.
TDR News; 1998 Oct; (57):2. PubMed ID: 12294756
[TBL] [Abstract][Full Text] [Related]
4. Visceral leishmaniasis in Africa.
Davidson R; Croft S
Afr Health; 1992 Jul; 14(5):18-9. PubMed ID: 12317771
[TBL] [Abstract][Full Text] [Related]
5. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine.
Sundar S; Rai M; Chakravarty J; Agarwal D; Agrawal N; Vaillant M; Olliaro P; Murray HW
Clin Infect Dis; 2008 Oct; 47(8):1000-6. PubMed ID: 18781879
[TBL] [Abstract][Full Text] [Related]
6. Oral miltefosine for the treatment of Indian visceral leishmaniasis.
Sundar S; Jha TK; Thakur CP; Bhattacharya SK; Rai M
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S26-33. PubMed ID: 16730038
[TBL] [Abstract][Full Text] [Related]
7. [Status of research and development for control of tropical diseases: hypocrisy, indifference or lack of coordination].
Millet P
Med Trop (Mars); 2006 Dec; 66(6):542-8. PubMed ID: 17286017
[TBL] [Abstract][Full Text] [Related]
8. TDR collaboration with the pharmaceutical industry.
Gutteridge WE
Trans R Soc Trop Med Hyg; 2006 Dec; 100 Suppl 1():S21-5. PubMed ID: 16730039
[TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
10. AIDSCAP seeks a private sector solution to the STD self-treatment dilemma.
Henry K
Aidscaptions; 1995 Mar; ():26-9. PubMed ID: 12319707
[TBL] [Abstract][Full Text] [Related]
11. Magnitude of unresponsiveness to sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar.
Das VN; Ranjan A; Bimal S; Siddique NA; Pandey K; Kumar N; Verma N; Singh VP; Sinha PK; Bhattacharya SK
Natl Med J India; 2005; 18(3):131-3. PubMed ID: 16130613
[TBL] [Abstract][Full Text] [Related]
12. MMV: New Medicines for Malaria Venture.
TDR News; 1999 Feb; (58):2, 4. PubMed ID: 12322122
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B lipid complex available for AIDS related cryptococcal meningitis. South Africa.
AIDS Wkly; 1993 Oct; ():8-9. PubMed ID: 12345310
[TBL] [Abstract][Full Text] [Related]
14. Amphotericin B colloidal dispersion for the treatment of Indian visceral leishmaniasis.
Sundar S; Mehta H; Chhabra A; Singh V; Chauhan V; Desjeux P; Rai M
Clin Infect Dis; 2006 Mar; 42(5):608-13. PubMed ID: 16447104
[TBL] [Abstract][Full Text] [Related]
15. Public-private partnership: from there to here.
Croft SL
Trans R Soc Trop Med Hyg; 2005 Oct; 99 Suppl 1():S9-14. PubMed ID: 16087204
[TBL] [Abstract][Full Text] [Related]
16. Global public-private partnerships against neglected diseases: building governance structures for effective outcomes.
Buckup S
Health Econ Policy Law; 2008 Jan; 3(Pt 1):31-50. PubMed ID: 18634631
[TBL] [Abstract][Full Text] [Related]
17. [Leishmaniasis--oral treatment with hexadecylphosphocholine].
Bommer W; Eibl HJ; Engel KR; Kuhlencord A; Sindermann H; Sundar S; Zappel H
Wien Klin Wochenschr; 2004; 116 Suppl 4():24-9. PubMed ID: 15683039
[TBL] [Abstract][Full Text] [Related]
18. Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis.
Sundar S; Jha TK; Sindermann H; Junge K; Bachmann P; Berman J
Pediatr Infect Dis J; 2003 May; 22(5):434-8. PubMed ID: 12792385
[TBL] [Abstract][Full Text] [Related]
19. Treatment of leishmaniasis with miltefosine: 2008 status.
Berman JJ
Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1209-16. PubMed ID: 18721114
[TBL] [Abstract][Full Text] [Related]
20. Miltefosine: oral treatment of leishmaniasis.
Soto J; Soto P
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):177-85. PubMed ID: 16597200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
